Researchers have computationally designed novel miniproteins aimed at neutralizing the IL-23 cytokine, a key driver of inflammatory diseases like IBD and psoriasis. Unlike existing treatments that target IL-23 receptors, these miniproteins directly address the IL-23 cytokine itself, specifically its p19 subunit. The study highlights challenges in de novo protein design, including scoring artifacts and the need for robust interface prediction, ultimately proposing five promising miniprotein candidates that engage critical binding sites and show no cross-reactivity with the p40 subunit. AI
IMPACT Demonstrates advanced AI applications in drug discovery and protein engineering.
RANK_REASON Academic paper detailing novel computational protein design methods and results. [lever_c_demoted from research: ic=1 ai=1.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
